Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy

American Journal of Kidney Diseases

Volumn 45, Issue 1, 2005, Pages 48-53

  Nakamura, Tsukasa ^a   Kawagoe, Yasuhiro ^a   Ogawa, Hiroshi ^a   Ueda, Yoshihiko ^b   Hara, Masanori ^c   Shimada, Noriaki ^d   Ebihara, Isao ^d   Koide, Hikaru ^d  

^a Shinmatsudo Central General Hospital   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Yoshida Hospital   (Japan)

^d KOTO HOSPITAL   (Japan)

Author keywords

apheresis; diabetic nephropathy; Low density lipoprotein (LDL); nephrotic syndrome; podocyte

Indexed keywords

CREATININE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MALE; NEPHROTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PODOCYTE; PROTEIN URINE LEVEL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; BLOOD COMPONENT REMOVAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINURIA;

EID: 11144321456     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.013     Document Type: Article

References (25)

1. F. Bonnet, M.E. Cooper, H. Kawachi, T.J. Allen, G. Boner, Z. Cao Irbesartan normalizes the deficiency in glomerular nephrin expression in a model of diabetes and hypertension Diabetologia 44 2001 874 877
2. M.E. Pagtalunan, P.L. Miller, S. Jumping-Eagle Podocyte loss and progressive glomerular injury in type II diabetes J Clin Invest 99 1997 342 348
3. T. Nakamura, C. Ushiyama, N. Shimada Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy Diabetes Care 23 2000 1168 1171
4. M. Hara, T. Yanagihara, I. Kihara Urinary podocytes in primary focal segmental glomerulosclerosis Nephron 89 2001 342 347
5. T. Nakao, M. Yoshino, H. Matsumoto Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy Kidney Int Suppl 71 1999 S206 S209
6. E. Muso, M. Yashiro, M. Matsushima, H. Yoshida, K. Sawanishi, S. Sasayama Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 9 1994 257 264
7. K. Yokoyama, S. Sakai, T. Sigematsu LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy Clin Nephrol 50 1998 1 7
8. R. Terkeltaub, C.L. Banka, J. Solan, D. Santoro, K. Brand, L.K. Curtiss Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity Arterioscler Thromb 14 1994 47 53
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 21 suppl 1 1998 S5 S22
10. H. Taniwaki, E. Ishimura, T. Kawagishi Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes Diabetes Care 26 2003 132 137
11. Y. Wang, M.C.Y. Ng, S.C. Lee Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes Diabetes Care 26 2003 2410 2415
12. E. Muso, M. Mune, Y. Fujii Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy Nephron 89 2001 408 415
13. V. Tesar, T. Zima, M. Kalousova Pathobiochemistry of nephrotic syndrome Adv Clin Chem 37 2003 173 218
14. W.E. Smoyer, P. Mundel Regulation of podocyte structure during the development of nephrotic syndrome J Mol Med 76 1998 172 183
15. J. Oh, J. Reiser, P. Mundel Dynamic organization of the podocyte actin cytoskeleton in the nephrotic syndrome Pediatr Nephrol 19 2004 130 137
16. K.E. White, R.W. Bilous Diabiopsies Study Group Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients Nephrol Dial Transplant 19 2004 1437 1443
17. T. Nakamura, C. Ushiyama, S. Suzuki Urinary excretion of podocytes in patients with diabetic nephropathy Nephrol Dial Transplant 15 2000 1379 1383
18. T. Nakamura, C. Ushiyama, S. Suzuki The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome Am J Nephrol 20 2000 175 179
19. W. Sulowicz, T. Stompor LDL-apheresis and immunoadsorption Novel methods in the treatment of renal diseases refractory to conventional therapy Nephrol Dial Transplant 18 suppl 5 2003 S59 S62
20. Y. Kamijo, Y. Kaneko, T. Ichikawa A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis Ther Apheresis 6 2002 459 462
21. J. Neugarten, D. Schlondorff Lipoprotein interactions with glomerular cells and matrix-lipids and renal disease W.F. Keane J.H. Stein Contemporary Issues in Nephrology vol 24 1991 Churchill Livingstone New York, NY 173 203
22. D. Schlondorff Cellular mechanisms of lipid injury in the glomerulus Am J Kidney Dis 22 1993 72 82
23. T. Lenz, T. Haak, J. Malek, H.J. Grone, H. Geiger, T. Gossmann Vascular endothelial growth factor in diabetic nephropathy Kidney Blood Press Res 26 2003 338 343
24. D.R. Cha, N.H. Kim, J.W. Yoon Role of vascular endothelial growth factor in diabetic nephropathy Kidney Int Suppl 77 2000 S104 S112
25. K. Shimada, T. Baba, S. Neugebauer Plasma vascular endothelial growth factor in Japanese type 2 diabetic patients with and without nephropathy J Diabetes Complications 16 2002 386 390